A-358 - Efficacy, safety and willingness to be retreated with tirbanibulin 1% ointment in patients with actinic keratosis over a field treatment up to 100 cm²

EJC Skin Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles